Obesity Surgery

, Volume 19, Issue 6, pp 791–795 | Cite as

Initial Japanese Experience with Intragastric Balloon Placement

  • Masayuki OhtaEmail author
  • Seigo Kitano
  • Seiichiro Kai
  • Akio Shiromizu
  • Hidetoshi Eguchi
  • Yuichi Endo
  • Takayuki Masaki
  • Tetsuya Kakuma
  • Hironobu Yoshimatsu
Research Article



We introduced intragastric balloon placement in Japan and evaluated the initial data.


Between December 2004 and March 2008, intragastric balloons [BioEnterics® Intragastric Balloon (BIB®) system] were placed in 21 Japanese patients with obesity [six women, 15 men; mean age 40 ± 9 years; mean body mass index (BMI) 40 ± 9 kg/m2]. The inclusion criteria were morbid obesity (BMI ≥ 35 kg/m2), the presence of obesity-related disorders, and failure with conventional treatments for at least 6 months. The balloon was routinely removed under endoscopy after 5 months.


No serious complications occurred, but in two of the 21 patients (9.5%), early removal (within 1 week) of the balloon was required due to continuous abdominal discomfort. Two other patients (9.5%) could not control their eating behavior and were considered unresponsive to the treatment, and their balloons were also removed before 5 months. Seventeen of the 21 patients (81%) finished the treatment, and the average weight loss and percent excess weight loss (%EWL) at the time the balloons were removed were 12 ± 5 kg and 27 ± 9%, respectively. Eight patients were followed for 1 year without intervention of consecutive bariatric surgery, and at that time, four of these patients had kept more than 20% of %EWL. The other patients regained their weight in the first year.


Intragastric balloon placement is a safe and effective procedure in obese Japanese patients, and about half of the patients will maintain their weight loss after the balloon is removed.


Morbid obesity Obesity Intragastric balloon Endoscopy Weight loss 



We thank Ms. Kazuyo Adachi and Yukiko Ishibashi for prescription and supervision of diet and Ms. Miho Sato and Midori Kono for patient management.


  1. 1.
    The Examination Committee of Criteria for ‘Obesity Disease’ in Japan, Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J. 2002;66:987–92.CrossRefGoogle Scholar
  2. 2.
    Ministry of Health, Labour and Welfare of Japan. The national health and nutrition survey in Japan, 2003 (in Japanese). Tokyo: Dai-ichi Shuppan Publishing Co. Ltd.; 2006.Google Scholar
  3. 3.
    Lee WJ, Wang W. Bariatric surgery: Asia-Pacific perspective. Obes Surg. 2005;15:751–7.CrossRefGoogle Scholar
  4. 4.
    Kitano S, Shiromizu A, Ohta M, et al. Intragastric balloon therapy for the treatment-resistant obesity (in Japanese). Gastroenterol Endosc. 2005;47:2197–201.Google Scholar
  5. 5.
    Fujimoto K, Sakata T, Etou H, et al. Charting of daily weight pattern reinforces maintenance of weight reduction in moderately obese patients. Am J Med Sci. 1992;303:145–50.CrossRefGoogle Scholar
  6. 6.
    Tokunaga K, Matsuzawa Y, Kotani K, et al. Ideal body weight estimated from the body mass index with lowest morbidity. Int J Obes. 1991;15:1–5.PubMedGoogle Scholar
  7. 7.
    Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17:565–8.CrossRefGoogle Scholar
  8. 8.
    Lee JS, Kawakubo K, Mori K, et al. Effective cut-off values of waist circumference to detect the clustering of cardiovascular risk factors of metabolic syndrome in Japanese men and women. Diab Vasc Dis Res. 2007;4:340–5.CrossRefGoogle Scholar
  9. 9.
    Nieben OG, Haboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet. 1982;1:198–9.CrossRefGoogle Scholar
  10. 10.
    Roman S, Napoleon B, Mion F, et al. Intragastric balloon for “non-morbid” obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2004;14:539–44.CrossRefGoogle Scholar
  11. 11.
    Galloro G, DePalma GD, Catanzano C, et al. Preliminary endoscopic technical report of a new silicone intragastric balloon in the treatment of morbid obesity. Obes Surg. 1999;9:68–71.CrossRefGoogle Scholar
  12. 12.
    Totte E, Hendrickk L, Pauwels M, et al. Weight reduction by means of intragastric device: experience with the Bioenterics Intragastric Balloon. Obes Surg. 2001;11:519–23.CrossRefGoogle Scholar
  13. 13.
    Sallet JA, Marchesini JB, Paiva DS, et al. Brazillian multicenter study of the intragastric balloon. Obes Surg. 2004;14:991–8.CrossRefGoogle Scholar
  14. 14.
    Genco A, Bruni T, Doldi SB, et al. BioEnterics Intragastric Balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161–4.CrossRefGoogle Scholar
  15. 15.
    Mui WLM, So WY, Yau PYP, et al. Intragastric balloon in ethnic obese Chinese: initial experience. Obes Surg. 2006;16:308–11.CrossRefGoogle Scholar
  16. 16.
    Ganesh R, Rao AD, Baladas HG, et al. The BioEnterics® Intragastric Balloon (BIB®) as a treatment for obesity: poor results in Asian patients. Singapore Med J. 2007;48:227–31.PubMedGoogle Scholar
  17. 17.
    Delgado-Aros S, Cremonini F, Castillo JE, et al. Independent influences of body mass and gastric volumes on satiation in humans. Gastroenterology. 2004;126:432–40.CrossRefGoogle Scholar
  18. 18.
    Cendes A, Burgos AM. Size, volume and weight of the stomach in patients with morbid obesity compared to controls. Obes Surg. 2005;15:1133–6.CrossRefGoogle Scholar
  19. 19.
    Puglisi F, Antonucci N, Capuano P, et al. Intragastric balloon and binge eating. Obes Surg. 2007;17:504–9.CrossRefGoogle Scholar
  20. 20.
    Hamoui N, Kingsbury S, Anthone GJ, et al. Surgical treatment of morbid obesity in schizophrenic patients. Obes Surg. 2004;14:349–52.CrossRefGoogle Scholar
  21. 21.
    Dixon JB, O’Brien PE. Selecting the optimal patient for LAP-BAND placement. Am J Surg. 2002;184:17S–20S.CrossRefGoogle Scholar
  22. 22.
    der Goederen-van der Meij S, Pierik RGJM, Pool MO, et al. Six months of balloon treatment does not predict the success of gastric banding. Obes Surg. 2007;17:88–94.CrossRefGoogle Scholar
  23. 23.
    Doldi SB, Micheletto G, Perrini MN, et al. Intragastric balloon: another option for treatment of obesity and morbid obesity. Hepato-Gastroenterology. 2004;51:294–7.PubMedGoogle Scholar
  24. 24.
    Herve J, Wahlen CH, Schaeken A, et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg. 2005;15:864–70.CrossRefGoogle Scholar
  25. 25.
    Mathus-Vliegen EMH, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc. 2005;61:19–27.CrossRefGoogle Scholar
  26. 26.
    Melissas J, Mouzas J, Filis D, et al. The intragastric balloon—smoothing the path to bariatric surgery. Obes Surg. 2006;16:897–902.CrossRefGoogle Scholar
  27. 27.
    Angrisani L, Lorenzo M, Borrelli V, et al. Is bariatric surgery necessary after intragastric baloon treatment? Obes Surg. 2006;16:1135–7.CrossRefGoogle Scholar
  28. 28.
    Busetto L, Segato G, De Luca M, et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case-control study. Obes Surg. 2004;14:671–6.CrossRefGoogle Scholar
  29. 29.
    Frutos MD, Morales MD, Lujan J, et al. Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass. Obes Surg. 2007;17:150–4.CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  • Masayuki Ohta
    • 1
    Email author
  • Seigo Kitano
    • 1
  • Seiichiro Kai
    • 1
  • Akio Shiromizu
    • 1
  • Hidetoshi Eguchi
    • 1
  • Yuichi Endo
    • 1
  • Takayuki Masaki
    • 2
  • Tetsuya Kakuma
    • 2
  • Hironobu Yoshimatsu
    • 2
  1. 1.Department of Surgery IOita University Faculty of MedicineYufuJapan
  2. 2.Department of Internal Medicine 1Oita University Faculty of MedicineYufuJapan

Personalised recommendations